Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with ...

LumiThera's key innovation is a device for use by ophthalmologists that improves vision and slows its loss, with a focus on ...

In addition to the proxy statement, STAAR has reached out to all stockholders to ask for their vote to adopt the merger ...

The studies compared the Unity Vitreoretinal Cataract System (VCS) to the Constellation Vision System and the ...

In conjunction with the definitive proxy filing, Staar (STAA) is mailing the following letter to Staar stockholders: “On August 5, 2025, we ...

Alcon (ALC) announced results from time and motion studies demonstrating efficiency with Unity Vitreoretinal Cataract System for vitreoretinal and ...

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it has filed its ...

Broadwood的代理文件聚焦STAAR的控制权变更支付，声称高管将获得超过5500万美元的加速股权奖励，其中包括首席执行官Stephen ...

Alcon (NYSE: ALC) shares registered just barely in the plus column Tuesday. The company, purporting to be the global leader in eye care dedicated to helping people see brilliantly, announced results ...

Some claims have been dismissed in the suit, which also involves Warner Bros., about imagery used at a 2024 Tesla event—but ...

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When ...

Broadwood’s filing marks the first organized campaign against the Alcon transaction. In its statement, Broadwood alleges that ...